BioStock: Sensidose is growing and sees opportunities in Finland

The pharmaceutical company Sensidose is growing and sees new opportunities in new markets. According to yesterday's year-end report, sales rose by 10.9 per cent in existing markets. At the same time, the company reported last week that the product Flexilev had been granted a subsidy in Finland. BioStock contacted CEO Jack Spira to learn more about new opportunities in Finland and continued market expansion.

Read the interview with Sensidose's CEO Jack Spira at biostock.se:

https://www.biostock.se/en/2023/02/sensidose-is-growing-and-sees-opportunities-in-finland/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/